Monday, December 04, 2017 8:09:48 PM
Eric
Date
Name-Position
Transaction
Shares
Price Range ($)
Shares Held
Mkt Value
11/29/17 Manko Joseph M Jr
Director and Beneficial O... Purchase 77,600 0.80 – 0.83 6,477,379 $63.6 K
11/24/17 Manko Joseph M Jr
Director and Beneficial O... Purchase 222,710 0.79 – 0.80 6,399,779 $177.3 K
11/8/17 Manko Joseph M Jr
Director and Beneficial O... Purchase 128,175 0.65 – 0.69 6,177,069 $84.6 K
9/29/17 Baker Paul Mark
Director Award of Options 5,896 0.53 – 0.53 1,860,685 $3.1 K
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM